Arantes-Oliveira, NunoSchneider, Anna Katharina2024-10-182024-10-182024-01-172024-01-17http://hdl.handle.net/10362/173716ProbiOxy is a biopharma start-up with a vision to develop the first probiotic treatment that effectively helps patients suffering from Inflammatory Bowel Disease relieve their symptoms and experience a transformative shift in their quality of life. Its strategic approach evolves around obtaining initial funding, licensing intellectual property, advancing through pre clinical and clinical trials, growing the patent portfolio, developing the product pipeline, and ultimately exiting through acquisition by a prominent pharmaceutical entity. Other important aspects of implementing such a business are preparing and managing the acquisition, and having a contingency plan in place.engScience-based entrepreneurshipProbioticsIbdEmerging treatmentsExit strategyExit marketM&APositioning for acquisitionContingency planTransaction valuemaster thesis203602161